"The Center for Biomedical Advanced Research and Development Authority (BARDA) is giving $72 million to three drugmakers to help fortify the US supply of bird flu vaccine ahead of 2025.....Sanofi, GSK and CSL will be asked to fill and finish additional doses of their influenza A(H5) vaccines in either pre-filled syringes or ready-to-use vials, ASPR said. Almost half of the $72 million — $34 million — is going to CSL, with the company committing about three million finished doses of its H5N1 vaccine...."
[Source: Endpoints NEWS]
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$240.21 |
Change
1.110(0.46%) |
Mkt cap ! $116.4B | |||
| Open | High | Low | Value | Volume |
| $238.55 | $241.28 | $237.66 | $30.37M | 126.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 171 | $240.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $240.21 | 1088 | 6 |
View Market Depth
| Last trade - 11.26am 17/06/2025 (20 minute delay) ? |
| CSL (ASX) Chart |